Tissue Array Specification Sheet


Product Name: Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR954 3 Slides Price: $2314, 5 Slides Price: $3777
Array Panel: Prostate adenocarcinoma tissue microarray, duplicated cores, 36 cancer and 8 of which has matched normal adjacent tissue and 3 cases of metastasis in bones and 1 in abdominal wall,with follow-up data
Cat No. Cases Layout Cores Diameter Thickness Standard IHC
PR953  40 8 x 12 96 1.5 mm 5 µm Anti-Actin confirmed

Microarray Panel Display

 
123456789101112
A Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro
B Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro
C Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro
D Abd Bon Bon Bon Pro Pro Pro Pro Pro Pro Pro Pro
E
F
G
H
Legend: Abd - Abdominal wall, Bon - Bone, Pro - Prostate

- , - Metastasis, -

Specification Sheet

Pos Sex Age Organ Pathology diagnosis Stage Gleason Score TNM Months Type †
A1 M 68 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
A2 M 64 Prostate Adenocarcinoma II 7 T2cN0M0 . Malignant
A3 M 71 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
A4 M 64 Prostate Adenocarcinoma III 10 T3aN0M0 . Malignant
A5 M 59 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
A6 M 65 Prostate Adenocarcinoma IV 8 T4N0M0 . Malignant
A7 M 73 Prostate Adenocarcinoma II 7 T2cN0M0 . Malignant
A8 M 69 Prostate Adenocarcinoma II 7 T2cN0M1 . Malignant
A9 M 62 Prostate Adenocarcinoma II 7 T2cN0M1 . Malignant
A10 M 66 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
A11 M 60 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
A12 M 70 Prostate Adenocarcinoma IV 7 T4N0M0 . Malignant
B1 M 65 Prostate Adenocarcinoma III 9 T3bN0M1 . Malignant
B2 M 67 Prostate Adenocarcinoma IV 9 T3bN1M0 . Malignant
B3 M 69 Prostate Adenocarcinoma III 7 T3bN0M0 . Malignant
B4 M 69 Prostate Adenocarcinoma III 7 T3aN0M1 . Malignant
B5 M 70 Prostate Adenocarcinoma III 7 T3aN0M1 . Malignant
B6 M 58 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
B7 M 71 Prostate Adenocarcinoma II 7 T2cN0M0 . Malignant
B8 M 70 Prostate Adenocarcinoma III 7 T3bN0M0 . Malignant
B9 M 59 Prostate Adenocarcinoma II 6 T2bN0M0 . Malignant
B10 M 63 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
B11 M 72 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
B12 M 66 Prostate Adenocarcinoma III 8 T3bN0M0 . Malignant
C1 M 70 Prostate Adenocarcinoma II 7 T2cN0M1 . Malignant
C2 M 68 Prostate Adenocarcinoma III 8 T3bN0M0 . Malignant
C3 M 63 Prostate Adenocarcinoma III 10 T3bN0M1 . Malignant
C4 M 57 Prostate Adenocarcinoma III 7 T3bN0M0 . Malignant
C5 M 72 Prostate Adenocarcinoma III 8 T2cN0M0 . Malignant
C6 M 70 Prostate Adenocarcinoma III 8 T3bN0M0 . Malignant
C7 M 75 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
C8 M 62 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
C9 M 63 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
C10 M 53 Prostate Adenocarcinoma III 9 T3bN0M0 . Malignant
C11 M 63 Prostate Adenocarcinoma III 8 T3bN0M0 . Malignant
C12 M 44 Prostate Adenocarcinoma III 7 T3bN0M1 . Malignant
D1 M 65 Abdominal wall Metastatic adenocarcinoma from prostate IV . M1 36 Metastasis
D2 M 61 Bone Metastatic adenocarcinoma from prostate IV . M1 32 Metastasis
D3 M 69 Bone Metastatic adenocarcinoma from prostate IV . M1 34 Metastasis
D4 M 59 Bone Metastatic adenocarcinoma from prostate IV . M1 0 Metastasis
D5 M 69 Prostate Normal (match of #8) . . . . Nat
D6 M 62 Prostate Normal (match of #9) . . . . Nat
D7 M 65 Prostate Normal (match of #13) . . . . Nat
D8 M 69 Prostate Normal (match of #16) . . . . Nat
D9 M 70 Prostate Normal (match of #17) . . . . Nat
D10 M 70 Prostate Normal (match of #25) . . . . Nat
D11 M 63 Prostate Normal (match of #27) . . . . Nat
D12 M 44 Prostate Normal (match of #36) . . . . Nat
, * Month, interval between primary and metastatic cancer, ** TNM and stage, AJCC Cancer Staging Manual (6th Edition), pTNM, pathological TNM, , . † For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

Staining Scoring: '-' - no staining; '+-' - borderline staining; '+' - weak staining; '++' - moderate staining; '+++' - strong staining; '%' - percentage of positive cells.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis
Home
Products
Contact Us
About Us

E-mail:

Password:

My Account
Cart (0 items)
$0.00